Asymmetric assessments in valuing pharmaceutical risks.
Viscusi
W K
WK
Harvard Law School, Cambridge, MA 02138, USA.
Magat
W A
WA
Scharff
R
R
D017277:Drug Approval / Q000331:legislation & jurisprudence*; D064420:Drug-Related Side Effects and Adverse Reactions; D017850:Economics, Pharmaceutical; D006801:Humans; D018570:Risk Assessment; D006113:United Kingdom; D014481:United States; D014486:United States Food and Drug Administration